<DOC>
	<DOCNO>NCT02214966</DOCNO>
	<brief_summary>The objective investigate relative bioavailability fix dose combination ( FDC ) tablet ( 80 mg telmisartan / 10 mg ramipril ) food intake comparison bioavailability FDC tablet fasting .</brief_summary>
	<brief_title>Influence Food Bioavailability Telmisartan / Ramipril Fixed Dose Combination Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Healthy male female accord follow criterion base upon complete medical history , include physical examination , vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test Age ≥18 ≤55 year Body mass index ( BMI ) ≥18.5 ≤29.9 kg/m2 Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial Use drug might reasonably influence result trial prolong QT/QTc interval base knowledge time protocol preparation within 10 day prior administration trial Participation another trial investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke 24 hour prior dose 24 hour dose Alcohol abuse ( 60 g/day ) inability stop alcoholic beverage 24 hour prior dose last sampling time point Drug abuse Blood donation ( 100 mL within four week prior administration trial ) Excessive physical activity ( within one week prior administration trial drug trial ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen trial site A marked baseline prolongation QT/QTc interval ( e.g . repeat demonstration QTc interval &gt; 450 m ) A history additional risk factor torsade de pointes ( e.g. , heart failure , hyperkalemia , hypokalemia , family history Long QT Syndrome ) Any history relevant low BP Supine blood pressure screen systolic &lt; 110 mm Hg diastolic &lt; 60 mm Hg History urticaria History angioneurotic edema Hereditary fructose intolerance Salt and/or volume depletion For female subject : Pregnancy / positive pregnancy test , plan become pregnant study within 1 month study completion No adequate contraception study 1 month study completion , i.e . implant , injectables , combine oral contraceptive , intrauterine device , sexual abstinence ( least 1 month prior enrolment ) , vasectomised partner ( vasectomy perform least 1 year prior enrolment ) surgical sterilisation ( incl . hysterectomy ) . Females , vasectomise partner , sexually abstinent surgically sterile ask additionally use barrier contraception method ( e.g . condom , diaphragm spermicide ) Currently lactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>